Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?

Medicine and Dentistry

• Observational Study 100%
• Pneumococcal Pneumonia 100%
• Streptococcus Pneumonia 100%
• Diseases 100%
• Pneumococcal Infection 66%
• Clinical Trial 33%
• Decision Making 33%
• Respiratory Tract Infection 33%
• Polysaccharide Vaccine 33%
• Pneumococcus Polysaccharide 33%
• Pneumococcus Vaccine 33%
• Lower Respiratory Tract Infection 33%

Keyphrases

• 13-valent Pneumococcal Conjugate Vaccine (PCV13) 100%
• Pneumococcal Vaccination 100%
• PPSV23 100%
• Vaccine Effectiveness 40%
• Pneumococcal Disease 40%
• Streptococcus Pneumoniae 30%
• Invasive Pneumococcal Disease 20%
• Clinical Trials 10%
• Next-generation Vaccines 10%
• Infectious Diseases 10%
• Google Scholar 10%
• PubMed 10%
• Vaccination 10%
• Literature Search 10%
• Adult Population 10%
• Inclusion Criteria 10%
• High-income Countries 10%
• Narrative Review 10%
• Respiratory Infection 10%
• PCV13 Vaccine 10%
• 23-valent Pneumococcal Polysaccharide Vaccine 10%
• Lower Respiratory Tract Infection 10%
• Vaccine Types 10%
• PCV20 10%
• Population Design 10%
• All-cause Pneumonia 10%
• Standardized Evaluation Framework 10%
• Population Outcomes 10%
• PCV15 10%
• Valency 10%
• Respiratory Outcomes 10%
• Vaccine Research 10%
• 20-valent Pneumococcal Conjugate Vaccine 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Observational Study 100%
• Streptococcus Pneumonia 100%
• Diseases 100%
• Pneumococcal Infection 66%
• Clinical Trial 33%
• Respiratory Tract Infection 33%
• Polysaccharide Vaccine 33%
• Pneumococcus Polysaccharide 33%
• Lower Respiratory Tract Infection 33%
• Pneumococcus Vaccine 33%